Guggenheim Capital’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,039
Closed -$1.9K 1858
2024
Q1
$1.9K Buy
+1,039
New +$1.9K ﹤0.01% 1866
2017
Q3
Sell
-10,921
Closed -$157K 2799
2017
Q2
$157K Sell
10,921
-341
-3% -$4.9K ﹤0.01% 2663
2017
Q1
$103K Buy
+11,262
New +$103K ﹤0.01% 2692